PPM1K and maple syrup urine disease: Reintroduction of BCKDH activity by transplantation of the liver from normal individuals was also beneficial, at least in pediatric patients, suggesting that systemic restoration of BCAA catabolism could be sufficient to treat MSUD patients at early ages46 (Table 1).